e-learning
resources
Munich 2006
Monday 04.09.2006
Acute respiratory failure: diagnostic procedures and clinical management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The clinical significance of serum and bronchoalveoalr lavage inflammatory cytokine in patients with acute respiratory failure due to severe community-acquired pneumonia
Y. L. Lee, Y. H. Liu, C. H. Chen, C. F. Chiu, C. M. Chen, C. M. Shih (Taichung, Taiwan, Province Of China)
Source:
Annual Congress 2006 - Acute respiratory failure: diagnostic procedures and clinical management
Session:
Acute respiratory failure: diagnostic procedures and clinical management
Session type:
Poster Discussion
Number:
2075
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. L. Lee, Y. H. Liu, C. H. Chen, C. F. Chiu, C. M. Chen, C. M. Shih (Taichung, Taiwan, Province Of China). The clinical significance of serum and bronchoalveoalr lavage inflammatory cytokine in patients with acute respiratory failure due to severe community-acquired pneumonia. Eur Respir J 2006; 28: Suppl. 50, 2075
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Local and systemic cytokine profiles in nonsevere and severe community-acquired pneumonia
Source: Eur Respir J 2013; 41: 1378-1385
Year: 2013
Systemic cytokine levels in community-acquired pneumonia and their association with disease severity
Source: Eur Respir J 2002; 20: 990-995
Year: 2002
Comparison of inflammatory response biomarkers to predict complications in hospitalized patients with community-acquired pneumonia
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011
Initial and persistent inflammatory response in treatment failure in community-acquired pneumonia
Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia
Year: 2007
Local and systemic cytokine profiles in patients with non-severe and severe community-acquired pneumonia
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012
Eosinophilic pneumonia (acute, chronic)
Source: Respipedia Article
Year: 2017
Enhanced neutrophil response in patients with chronic bronchitis and community-acquired pneumonia (CAP)
Source: Eur Respir J 2002; 20: Suppl. 38, 418s
Year: 2002
CD4 as a predictor of systemic inflammatory response and death at severe community-acquired pneumonia
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013
Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 42s
Year: 2007
The relation between pathogenic bacteriology in sputum and lung function in patients with acute exacerbation of COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 592s
Year: 2002
Difference of immune response in patients with severe acute pneumonia and lung abscesses
Source: Eur Respir J 2004; 24: Suppl. 48, 189s
Year: 2004
Community-acquired pneumonia as a cause of acute respiratory failure (ARF) in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 518s
Year: 2005
The influence of acute respiratory tract infection on the serum levels of KL-6 and SP-D in chronic interstitial pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 825s
Year: 2006
BAL and microbiological surveillance of nosocomial pneumonia in ARDS patients
Source: Eur Respir J 2006; 28: Suppl. 50, 786s
Year: 2006
The role of inflammatory parameters in the diagnosis and management of patients with community-acquired pneumonia
Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens
Year: 2012
How can I differentiate community-acquired pneumonia (CAP)+COPD patients from acute exacerbation of COPD (AECOPD) patients?
Source: International Congress 2015 – Differentiating COPD exacerbations from pneumonia in COPD patients
Year: 2015
An unbalanced inflammatory response on admission impacts clinical stability in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011
Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Serum procalcitonin (PCT-Q) as a diagnostic tool for bacterial lower respiratory tract infection among COPD patients with acute exacerbation
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept